Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Toggle navigation
Contact Us
Subscribe
Promote Your Event
e-Edition
Privacy Policy
Terms of Service
Local Weather
Home Delivery
Submission Forms
News
Local News
The Leader
Heartland News
Sports
Entertainment
Local Events
Multimedia
Photo Galleries
Videos
Obituaries
Classifieds
Real Estate
Property for Rent
Cars & Vehicles
Jobs
Items for Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place an ad
Legals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dermtech Inc
(NQ:
DMTK
)
2.570
+0.060 (+2.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dermtech Inc
< Previous
1
2
3
4
5
6
Next >
DermTech Announces Publication of New GvHD Clinical Research Conducted in Collaboration with Memorial Sloan Kettering Cancer Center
April 28, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Expands Telehealth Application, DermTech Connect, Across 44 States
April 26, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech to Showcase DermTech Stratum, an Expanded Translational Medicine Service Offering, at San Diego’s Inaugural ‘Innovation Day’ Event
April 25, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech: Q4 Earnings Insights
March 01, 2022
DermTech (NASDAQ:DMTK) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DermTech...
Via
Benzinga
DermTech Announces Release Date for First-Quarter 2022 Financial Results
April 14, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 28, 2022
From
DermTech, Inc.
Via
Business Wire
Earnings Scheduled For March 1, 2022
March 01, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...
Via
Benzinga
Earnings Outlook For DermTech
February 28, 2022
DermTech (NASDAQ:DMTK) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
DermTech Management to Present at Upcoming Investor Conferences
February 24, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Welcomes Adelle Walker as Vice President of Consumer Products
February 23, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech to Announce Fourth Quarter and Full-Year Financial Results
February 15, 2022
From
DermTech, Inc.
Via
Business Wire
DermTech Management to Participate in Upcoming Investor Conferences
January 31, 2022
From
DermTech, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
January 07, 2022
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 03, 2022
Gainers Indaptus Therapeutics (NASDAQ:INDP
Via
Benzinga
63 Biggest Movers From Friday
December 20, 2021
Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15...
Via
Benzinga
DermTech Unveils DermTech Stratum, an Expanded Translational Medicine Service Offering for Non-invasive Biomarker Analysis
November 29, 2021
From
DermTech, Inc.
Via
Business Wire
This Is the Main Problem With DermTech's Q3 Results
November 20, 2021
Nothing major changed for the skin genomics company in Q3.
Via
The Motley Fool
DermTech Presents Precision Approaches to Personalized Dermatology at 2021 Dermatology Drug Development Summit
November 18, 2021
From
DermTech, Inc.
Via
Business Wire
Better Buy: 10x Genomics vs. DermTech
November 11, 2021
Both companies offer disruptive new solutions in their niches of the healthcare space.
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 10, 2021
Gainers Valneva (NASDAQ:VALN) shares increased by 24.51% to $50.34 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 10, 2021
Good morning, trader! It's time to start another busy day of trading with a dive into the biggest pre-market stock movers for Wednesday.
Via
InvestorPlace
30 Stocks Moving in Wednesday's Pre-Market Session
November 10, 2021
Gainers RenovoRx, Inc. (NASDAQ: RNXT) rose 113% to $11.50 in pre-market trading. The company, on Tuesday evening, made a presentation on intra-arterial chemotherapy as a...
Via
Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
DermTech Reports Third Quarter 2021 Financial Results
November 09, 2021
From
DermTech, Inc.
Via
Business Wire
DermTech's Return On Capital Employed Overview
November 09, 2021
DermTech (NASDAQ:DMTK) brought in sales totaling $3.12 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 29.03%, resulting in a loss of $17...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 09, 2021
Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the...
Via
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
DermTech and DermatologistOnCall Enter Agreement to Improve Access to the DermTech Melanoma Test with Noninvasive, At-Home Sample Collection
November 08, 2021
From
DermTech, Inc.
Via
Business Wire
DermTech Management to Participate in Upcoming Investor Conferences
November 02, 2021
From
DermTech, Inc.
Via
Business Wire
DermTech to Announce Third Quarter Financial Results on November 9, 2021
October 26, 2021
From
DermTech, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.